Prescription Drug Payment Act, c. P-15.01

Section 2.11

Payment by manufacturer

Cite as Prescription Drug Payment Act, c. P-15.01, s. 2.11 · current to June 16, 2023 · read from New Brunswick Acts and Regulations on November 16, 2026

The text

(1) Where a manufacturer requests that the Minister include a drug produced by it in the New Brunswick Prescription Drug Program Formulary, the manufacturer shall (a) provide the Minister with the information prescribed by regulation and any other information that the Minister requires, and (b) pay to the Minister an amount in respect of expenses incurred or to be incurred by the Minister or any advisory committee advising the Minister with respect to a determination as to the listing of the drug in the New Brunswick Prescription Drug Program Formulary. (2) The Minister may, before or after a determination in respect of a drug as to its suitability for listing in the New Brunswick Prescription Drug Program Formulary, assess the manufacturer for the expenses incurred or to be incurred by the Minister or an advisory committee advising the Minister with respect to the determination. (3) When making an assessment under subsection (2), the Minister shall take into consideration (a) the portion of the expenses of the Minister and the members of any advisory committee advising the Minister that relate to the determination, (b) the expenses of any experts or consultants retained by the Minister or any advisory committee advising the Minister that relate to the determination, and (c) such other costs and expenses that the Minister considers reasonable that are incurred by the Minister or any advisory committee advising the Minister that relate to the determination. (3.1) Members of all advisory committees who are not employees of the Civil Service, as defined in the Civil Service Act, are entitled to daily allowances fixed by the Minister. (4) Within sixty days after the decision of the Minister in respect of the suitability of the drug for listing in the New Brunswick Prescription Drug Program Formulary, the Minister shall (a) rebate the manufacturer the amount by which the expenses assessed under subsection (2) exceed the actual expenses of the Minister and any advisory committee advising the Minister, (b) assess the manufacturer for the amount by which the actual expenses of the Minister and any advisory committee advising the Minister exceed the expenses assessed under subsection (2), or (c) assess the manufacturer for the actual expenses incurred by the Minister and any advisory committee advising the Minister, if no assessment has been made.
Read the Prescription Drug Payment Act on the Province's website ↗